Loading…
Investigation of Isolated Blastocystis Subtypes from Cancer Patients in Turkey
Purpose It is not clear that Blastocystis remains without damage to the digestive tract or has a pathogenic effect in relation to subtypes in immunocompromised people, such as cancer patients. The present study aimed to investigate the frequency and subtype distribution of Blastocystis in cancer pat...
Saved in:
Published in: | Acta parasitologica 2021-06, Vol.66 (2), p.584-592 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
It is not clear that
Blastocystis
remains without damage to the digestive tract or has a pathogenic effect in relation to subtypes in immunocompromised people, such as cancer patients. The present study aimed to investigate the frequency and subtype distribution of
Blastocystis
in cancer patients who were followed-up and treated in the Oncology clinic of Firat University Hospital and to determine the clinical signs of infected sufferers.
Methods
201 patients aged ≥ 18 with a diagnosis of cancer were enrolled in this cross-sectional study. Patients’ stool samples were examined between September 2017 and August 2019 by native-Lugol, trichrome staining. Microscopy-positive stool samples were subjected to DNA isolation and subtyped by Sequence Tagged Site (STS)-PCR analysis. The symptoms and demographic characteristics of the patients were also evaluated.
Results
Totally, 29 (14.4%) samples were positive for
Blastocystis
after all methods. 15 (51.7%) out of 29 samples were successfully subtyped by the sequenced-tagged site(STS)-PCR, while 14 (48.3%) could not be typed. Three subtypes of
Blastocystis
were detected: ST3 (40%), ST2 (33%), ST1 (20%), and one mixed infections with ST1/ST2 (6%). There was no statistically significant difference in terms of clinical findings and demographic characteristics.
Conclusion
The outcomes of our study promote the idea that
Blastocystis
could be an asymptomatic and harmless commensal organism. However, more comprehensive molecular and clinical studies are needed to fully determine the pathogenicity and epidemiology of
Blastocystis
in cancer patients. |
---|---|
ISSN: | 1230-2821 1896-1851 |
DOI: | 10.1007/s11686-020-00322-y |